A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Numab Therapeutics AG
Mayo Clinic
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
MacroGenics
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Anza Therapeutics, Inc.